Mohammed Khalil Mohammed Ali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammed Khalil Mohammed Ali has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- A. I. Aljameel A. I. Aljameel
Department of Physics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia
1 shared publication - Abueliz Modwi
Department of Chemistry, College of Science, Qassim University, Buraydah, Saudi Arabia
1 shared publication - Ammar Al-Farga
Department of Biochemistry, College of Sciences, University of Jeddah, Jeddah, Saudi Arabia
1 shared publication - E. M. Mkawi
School of Physics Universiti Sains Malaysia
1 shared publication Fatma Mohamed A. Abid
Department of Chemistry, Faculty of Science, AlAzzaytuna University, Tarhuna 537622224, Libya
1 shared publicationH. M. El-Khair
Al Imam Mohammad Ibn Saud Islamic University (IMSIU)
1 shared publication
Latest Publications
- 15 April 2026
- Published by Bentham Science Publishers Ltd. in Current Organic Synthesis
- Vol. 23 (2) , 98-117
Synthetic Progress and Antifungal Potential of Thiophene Chalcone Derivatives: A Review
Fungal infections constitute a major global health concern, with annual mortality rates exceeding those of tuberculosis and malaria. This troubling situation has been exacerbated by the emergence of multidrug-resistant fungal strains, which have significantly undermined the effectiveness of current treatments. A number of antifungal medicines are now being utilised in clinical practice. Some of these treatments include azoles, polyenes, pyrimidines, and echinocandins. However, the therapeutic efficacy of these drugs is becoming increasingly limited due to the presence of unwanted side effects, drug-drug interactions, and the rapid development of resistant fungal strains. This growing concern underscores the urgent need for novel antifungal drugs that are safer and more effective than those currently available. Chalcone compounds, whether they are natural or synthetic, have demonstrated significant pharmacological potential due to their extensive range of biological activities. This can be mostly related to the presence of the reactive α, β-unsaturated carbonyl group that is characteristic of chalcones. Furthermore, thiophene is an important scaffold in medicinal chemistry owing to its diverse biological applications. This review article is structured into two main parts. The first part provides an overview of the synthesis of thiophene chalcone derivatives using conventional methods via the Claisen-Schmidt condensation reaction, highlighting the reaction conditions, catalysts, solvent systems, time, and reported yields from recent studies. The second part presents a summary of thiophene chalcone derivatives evaluated over the past decade (2015-2025) for their antifungal properties, discussing the assays performed, fungal strains tested, and the overall biological outcomes reported.
- 15 April 2026
- Published by Bentham Science Publishers Ltd. in Current Organic Synthesis
- Vol. 23 (2) , 98-117
Synthetic Progress and Antifungal Potential of Thiophene Chalcone Derivatives: A Review
Fungal infections constitute a major global health concern, with annual mortality rates exceeding those of tuberculosis and malaria. This troubling situation has been exacerbated by the emergence of multidrug-resistant fungal strains, which have significantly undermined the effectiveness of current treatments. A number of antifungal medicines are now being utilised in clinical practice. Some of these treatments include azoles, polyenes, pyrimidines, and echinocandins. However, the therapeutic efficacy of these drugs is becoming increasingly limited due to the presence of unwanted side effects, drug-drug interactions, and the rapid development of resistant fungal strains. This growing concern underscores the urgent need for novel antifungal drugs that are safer and more effective than those currently available. Chalcone compounds, whether they are natural or synthetic, have demonstrated significant pharmacological potential due to their extensive range of biological activities. This can be mostly related to the presence of the reactive α, β-unsaturated carbonyl group that is characteristic of chalcones. Furthermore, thiophene is an important scaffold in medicinal chemistry owing to its diverse biological applications. This review article is structured into two main parts. The first part provides an overview of the synthesis of thiophene chalcone derivatives using conventional methods via the Claisen-Schmidt condensation reaction, highlighting the reaction conditions, catalysts, solvent systems, time, and reported yields from recent studies. The second part presents a summary of thiophene chalcone derivatives evaluated over the past decade (2015-2025) for their antifungal properties, discussing the assays performed, fungal strains tested, and the overall biological outcomes reported.
- 14 November 2017
- Published by Springer Nature in Journal of Materials Science: Materials in Electronics
- Vol. 29 (4) , 2791-2796
Structural and optical characteristic of chalcone doped ZnO nanoparticles
- 14 November 2017
- Published by Springer Nature in Journal of Materials Science: Materials in Electronics
- Vol. 29 (4) , 2791-2796
Structural and optical characteristic of chalcone doped ZnO nanoparticles
- 21 October 2014
- Published by Springer Nature in Journal of Materials Science: Materials in Electronics
- Vol. 26 (1) , 222-228
Influence of substrate temperature on the properties of electrodeposited kesterite Cu2ZnSnS4 (CZTS) thin films for photovoltaic applications
- 21 October 2014
- Published by Springer Nature in Journal of Materials Science: Materials in Electronics
- Vol. 26 (1) , 222-228
Influence of substrate temperature on the properties of electrodeposited kesterite Cu2ZnSnS4 (CZTS) thin films for photovoltaic applications